Further Evidence of Increasing Diversity of Plasmodium vivax in the Republic of Korea in Recent Years. by Kim, Jung-Yeon et al.
Kim, JY; Goo, YK; Zo, YG; Ji, SY; Trimarsanto, H; To, S; Clark, TG;
Price, RN; Auburn, S (2016) Further Evidence of Increasing Diver-
sity of Plasmodium vivax in the Republic of Korea in Recent Years.
PLoS One, 11 (3). e0151514. ISSN 1932-6203 DOI: 10.1371/jour-
nal.pone.0151514
Downloaded from: http://researchonline.lshtm.ac.uk/2535618/
DOI: 10.1371/journal.pone.0151514
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
RESEARCH ARTICLE
Further Evidence of Increasing Diversity of
Plasmodium vivax in the Republic of Korea in
Recent Years
Jung-Yeon Kim1*, Youn-Kyoung Goo1,2, Young-Gun Zo3, So-Young Ji1,
Hidayat Trimarsanto4,5, Sheren To6, Taane G. Clark7,8, Ric N. Price6,9, Sarah Auburn6*
1 Division of Malaria and Parasitic Diseases, National Institute of Health, Korea CDC, Osong Saeng-
myeong, 2 ro, Osong Health Technology Administration, Osong, Republic of Korea, 2 Department of
Parasitology and Tropical Medicine, Kyungpook National University School of Medicine, Daegu, 700–422,
Republic of Korea, 3 Department of Molecular Parasitology, Sungkyunkwan University School of Medicine
and Center for Molecular Medicine, Samsung Biomedical Research Institute, Suwon, Gyeonggi-do 440–746,
Republic of Korea, 4 Eijkman Institute for Molecular Biology, Jl. Diponegoro 69, Jakarta Pusat, 10430,
Indonesia, 5 Agency for Assessment and Application of Technology, Jl. MH Thamrin 8, Jakarta, 10340,
Indonesia, 6 Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin
University, Darwin, NT 0810, Australia, 7 Faculty of Infectious and Tropical Diseases, London School of
Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom, 8 Faculty of
Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street,
London, WC1E 7HT, United Kingdom, 9 Centre for Tropical Medicine and Global Health, Nuffield
Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom
* Sarah.Auburn@menzies.edu.au (SA); jykim-malaria@nih.go.kr (JYK)
Abstract
Background
Vivax malaria was successfully eliminated from the Republic of Korea (ROK) in the late
1970s but re-emerged in 1993. Two decades later as the ROK enters the final stages of
malaria elimination, dedicated surveillance of the local P. vivax population is critical. We
apply a population genetic approach to gauge P. vivax transmission dynamics in the ROK
between 2010 and 2012.
Methodology/Principal Findings
P. vivax positive blood samples from 98 autochthonous cases were collected from patients
attending health centers in the ROK in 2010 (n = 27), 2011 (n = 48) and 2012 (n = 23). Para-
site genotyping was undertaken at 9 tandem repeat markers. Although not reaching signifi-
cance, a trend of increasing population diversity was observed from 2010 (HE = 0.50 ± 0.11)
to 2011 (HE = 0.56 ± 0.08) and 2012 (HE = 0.60 ± 0.06). Conversely, linkage disequilibrium
declined during the same period: IAS = 0.15 in 2010 (P = 0.010), 0.09 in 2011 (P = 0.010)
and 0.05 in 2012 (P = 0.010). In combination with data from other ROK studies undertaken
between 1994 and 2007, our results are consistent with increasing parasite divergence
since re-emergence. Polyclonal infections were rare (3% infections) suggesting that local
out-crossing alone was unlikely to explain the increased divergence. Cases introduced from
an external reservoir may therefore have contributed to the increased diversity. Aside from
one isolate, all infections carried a short MS20 allele (142 or 149 bp), not observed in other
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studies in tropical endemic countries despite high diversity, inferring that these regions are
unlikely reservoirs.
Conclusions
Whilst a number of factors may explain the observed population genetic trends, the available
evidence suggests that an external geographic reservoir with moderate diversity sustains the
majority of P. vivax infection in the ROK, with important implications for malaria elimination.
Introduction
Across the globe, P. vivax infection is recognised as a major cause of morbidity and in some
locations associated with mortality [1]. The direct and indirect morbidity and associated mor-
tality of P. vivax has a massive impact on the poorest communities of malarious countries.
Conservative estimates of the overall global cost of P. vivax infection to the individual in terms
of lost productivity, healthcare costs and transport to clinics are between $1.4 and 4.0 billion
per year[2]. The clinical and economic burden and the rise of P. vivax resistant to chloroquine,
the first-line treatment against the blood stages of vivax malaria in many endemic countries,
emphasize the importance of containing and eliminating the parasite [3].
Since the re-emergence of malaria in 1993 [4], the Republic of Korea (ROK) has faced sig-
nificant challenges in its endeavour to contain the spread of P. vivax infection and ultimately
achieve malaria-free status again. In the early phase of the re-emergence, malaria cases were
observed primarily in military personnel and veterans deployed near the demilitarized zone
bordering the Democratic People’s Republic of Korea (DPRK). However in the subsequent two
decades the proportion of P. vivax infections in the civilian population has gradually increased,
as has the incidence of cases in southern parts of the country [5]. With increasing population
movements for social and economic purposes, the risks of drug resistance importation from
overseas as well as along border regions, present an important threat to public health. A recent
study in the ROK highlighted evidence of local P. vivax infection resistant to chloroquine [6],
possibly reflecting importation from areas of established parasite drug resistance.
As the ROK enters the malaria pre-elimination phase, dedicated surveillance of the parasite
population is critical [7]. During this phase, strategies are needed to identify the remaining
pockets of infection and their major reservoirs, to detect and characterize imported cases, mon-
itor the efficacy of ongoing interventions, and identify emerging outbreaks as early as possible.
Previous studies in the ROK conducted between 1994 and 2007, have demonstrated the utility
of polymorphic short-tandem repeat (STR) markers such as microsatellites to inform on the
transmission dynamics of the local parasite population [8–10]. Indeed, STR-based approaches
have been increasingly applied to population genetic studies of P. vivax, with useful insights
derived into local transmission dynamics in a broad range of endemic settings [11–30].
Using a panel of nine standard STRmarkers selected for use by the Asia Pacific Malaria Elimina-
tion Network (APMEN) VivaxWorking Group [31], we genotyped a selection of autochthonous
and imported P. vivax infections collected in the ROK between 2010 and 2012.We describe the local
population diversity and structure, including comparison to prior molecular analyses in the ROK.
Methods
Ethics
All samples were collected with written informed consent from the patient, parent or legal
guardian (for individuals less than 18 years of age). The study was approved by the Korea
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Centers for Disease Control and Prevention Institutional Review Board, Republic of Korea
(Protocol No. 2011-02CON-14-P) and the Human Research Ethics Committee of Northern
Territory Department of Health and Menzies School of Health Research (HREC-2012-1895).
Study Sites and Sample Collection
Approximately 5 ml venous blood samples preserved in EDTA-coated vacutainers were col-
lected from 101 patients with P. vivax positive infection confirmed by microscopy of Giemsa-
stained blood films, presenting to local health centers and hospitals across the ROK between
April 2010 and September 2012. Fig 1 illustrates the administrative regions from which sam-
ples were sourced. All blood samples were stored in a fridge or freezer and transported to the
Korea Centres for Disease Control (KCDC) in Seoul within 24 hours of collection. Details on
recent travel history and home address were recorded for each patient in order to determine
the most likely location at which the infection was acquired.
Molecular Processing
Genomic DNA extraction was undertaken at the KCDC. Extractions were performed on 200 μl
of whole blood using the QIAamp DNAMini kit (Qiagen, USA) according to the manufactur-
er’s protocol. Nested PCR was performed to confirm the microscopy diagnosis of vivax malaria
[33].
P. vivax genotyping was undertaken at 9 previously described short tandem repeat markers
selected as a consensus panel for genotyping studies in the APMEN Vivax Working Group.
The marker selection comprises Pv3.27, msp1F3, MS1, MS5, MS8, MS10, MS12, MS16 and
MS20 [19, 34]. In addition to analyses on the full spectrum of 9 markers, investigations were
Fig 1. Locations at which infections were acquired. This map was generated by the Malaria Atlas Project,
University of Oxford. The colour scale reflects the model-based geostatistical point estimates of the annual
mean P. vivax parasite rate in the 1–99 year age range (PvPR) within the stable spatial limits of P. vivax
transmission in 2010 [32]. The approximate locations of the study sites are indicated with black dots. All MAP
maps are available to users under the CCAL 3.0. http://www.map.ox.ac.uk/about-map/open-access/.
doi:10.1371/journal.pone.0151514.g001
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undertaken on a subset of 5 markers (MS1, MS5, MS10, MS12 and MS20) defined as exhibiting
balanced diversity in a recent investigation of the correlation between diversity and local
endemicity in a panel of commonly used P. vivax STR markers [35]. This study demonstrated
that the markers with balanced diversity were optimal for characterising population structure,
whilst markers with excess diversity such as MS16, pv3.27 and MS8 had enhanced ability to
identify polyclonal infections. The Pv3.27, MS16 and msp1F3 loci were amplified using the
methods described by Abdullah et al. [11]. The MS1, MS5, MS8, MS10, MS12 and MS20 loci
were amplified using a single round of PCR following the protocol described by Gunawardena
et al. [16]. The primer sequences and chromosomal locations used for each marker are detailed
in Abdullah et al. [11].
The final labelled PCR products were diluted and sized by denaturing capillary electropho-
resis at Charles Darwin University on an ABI 3100 Genetic Analyzer with GeneScan LIZ-600
(Applied Biosystems) internal size standards. Genotype calling was facilitated with GeneMap-
per Version 4.0. In order to reduce potential artefacts from background noise or stutter, an
arbitrary fluorescent intensity threshold of 100 rfu was applied for peak detection. All electro-
pherogram traces were also inspected manually. For each isolate, at each locus, the predomi-
nant allele (highest intensity peak), and any additional alleles with peak height at least one-
third of the height of the predominant allele were scored [36]. Genotyping success was defined
as the presence of at least one allele at a given locus in a given sample.
Population Genetic Analysis
Since asexual P. vivax stages are haploid, an infection was defined as polyclonal if more than
one allele was observed at one or more loci. The Multiplicity of Infection (MOI) for a given
sample was defined as the maximum number of alleles observed at any of the loci investigated.
The mean MOI was calculated from the individual sample MOIs for each study site. With the
exception of the MOI calculations, in all analyses, only the predominant allele at each locus in
each isolate was used [36].
The expected heterozygosity (HE) was measured as an index of population diversity. HE was
calculated for each locus using the formulaHE = [n/ (n-1)] [1-Sp i
2], where n is the number of
isolates analyzed and pi is the frequency of the ith allele in the population. The correction factor
n/(n-1) was included to enhance comparison between populations with differing sample size.
The pairwise FST metric was used to gauge the genetic distance between populations. Calcu-
lations were undertaken using Arlequin software (version 3.5) [37]. In addition to the classic
FST metric, standardized measures of the genetic distance (F’ST) were calculated to adjust for
high marker diversity and enable greater comparability with other studies [38]. The F’ST pro-
vides a measure of FST expressed as a fraction of the maximum possible value of this statistic,
whereby F’ST = FST /FST−max. FST−max was calculated by recoding the data to obtain the maxi-
mum divergence among populations.
Population structure was further assessed using STRUCTURE software version 2.3.3 to
determine the most likely number of populations (K) and ancestry of each isolate to the K pop-
ulations [39]. Twenty replicates, with 10,000 iterations (10,000 burn-in) and were run for each
of K from 1–10 using the model parameters of admixture with correlated allele frequencies.
The most probable K was derived by calculating ΔK as described elsewhere [40] for each of
K = 2–8. Barplots illustrating the ancestry of each isolate to each of the K populations were pre-
pared using distruct software version 1.1 [41].
Multi-locus genotypes (or infection haplotypes) were reconstructed from the predominant
allele at each locus in isolates with no missing data at any of the loci investigated. Using these
multi-locus genotypes, linkage disequilibrium (LD) was measured by the standardised index of
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association (IA
S) using the web-based LIAN 3.5 software [42]. Under the null hypothesis of
linkage equilibrium, the significance of the IA
S estimates was assessed using 10,000 random
permutations of the data. LD was assessed in 1) the full sample set and 2), for assessment of
epidemic transmission, with each unique haplotype represented just once.
Using the multi-locus genotypes described above, the genetic relatedness between sample
pairs was assessed by measuring the proportion of alleles shared between haplotype pairs (ps).
Using (1-ps) as a measure of genetic distance [43], an unrooted neighbour-joining tree [44]
was generated with the APE (Analysis of Phylogenetics and Evolution) package in R [45]. Sus-
pected imported cases were included in the neighbour-joining analysis only.
Statistical Tests
Comparison of the patient age distributions between study years were undertaken using the
Wilcoxon rank sum test with continuity correction. The Kruskal-Wallis test was used to com-
pare the expected heterozygosity (HE) between study years. Assessment of the significance of
the difference in the proportion of male patients between the study years was determined using
Pearson's Chi-squared test with Yates' continuity correction. All statistical tests were performed
using R software [46]. Significance was determined at an alpha of 0.05.
Results
Samples and Genotyping
Between January 2010 and December 2012, a total of 101 parasite isolates were collected from
patients infected with P. vivax, three of whom had a travel history consistent with imported
infections from Cambodia, Brazil and Ethiopia. Patient and parasitological details for the para-
site isolates are summarised in Table 1. Amongst the 98 patients with autochthonous infec-
tions, 64 (65%) were male, with no significant difference observed between study years (P
<0.05). All three patients with likely imported cases were male. The median (range) age of
patients with autochthonous infections was 45 years (12–74 years), with no significant differ-
ences observed between years (P<0.05).
Details of the parasite genotypes at each locus are presented in the supplementary material
(S1 Table). After the exclusion of 2 autochthonous ROK isolates with high genotype failure (7
and 9 failed markers), 96 (98%) ROK samples and 3 (100%) imported cases (with at most 2
genotype fails) were available for molecular analysis. Amongst these, all 3 imported samples
(100%) and 77 (80%) ROK isolates, including 24 (89%) from 2010, 34 (74%) from 2011 and 19
(83%) from 2012, exhibited successful calls at all nine markers, enabling the reconstruction of
multi-locus genotypes (MLGs) for neighbour-joining and LD analyses. All markers displayed
less than 10% genotyping failures (range: 0–8% fails) (S2 Table).
Table 1. Sample details.
Year No. patients No. males (%) Median patient age, years (range) *
2010 27 18 (67%) 49 (12–63)
2011 48 33 (69%) 43 (15–74)
2012 23 13 (57%) 47 (20–73)
2010–12 98 64 (65%) 45 (12–74)
* Details on median patient age were missing for 9, 20 and 11 individuals in 2010, 2011 and 2012
respectively.
doi:10.1371/journal.pone.0151514.t001
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Polyclonality and Population Diversity
A total of 3.1% (3/96) ROK samples (n = 1 in 2010, n = 1 in 2011 and n = 1 in 2012) were poly-
clonal. The complexity of the polyclonal infections was low, in each case with only one locus
displaying evidence of multiple alleles, and a maximum of 2 alleles observed at any given locus.
This was reflected in an overall mean MOI of 1.03 clones per infection (1.04 in 2010, 1.02 in
2011 and 1.04 in 2012). On adjusting the relative threshold for calling minor alleles from 33%
to 10%, 6.2% (6/96) ROK samples were polyclonal.
At the population level, the average diversity across 2010 to 2012 was moderate (HE = 0.56;
Table 2). When stratified by year, a moderate increase was observed in the expected heterozy-
gosity fromHE = 0.5 in 2010 to 0.56 in 2011 and 0.60 in 2012, although this did not reach sta-
tistical significance (P<0.05). In comparison with other microsatellite-based studies where the
diversity of P. vivax in the ROK was assessed in earlier years [8, 10], our results demonstrate a
continual increase in diversity from 1994 to 2013 (Table 3).
Whilst differences were observed in the dynamics of individual markers over time in our
study, the four markers with the overall lowest diversity (MS8, MS10, MS12 and MS20; all
HE<0.5) all demonstrated moderate increases in diversity from 2010 to 2011 and 2012. These
Table 2. Marker diversity by year between 2010 and 2013.
2010–12 2010 2011 2012
Marker HE HE HE HE Pattern of change
MS5 0.79 0.80 0.79 0.80 Stable
MS16 0.79 0.75 0.80 0.75 Fluctuation
pv3.27 0.75 0.78 0.76 0.72 Decline
MS1 0.73 0.77 0.71 0.76 Fluctuation
msp1f3 0.73 0.70 0.76 0.74 Fluctuation
MS8 0.36 0.21 0.37 0.44 Increase
MS10 0.35 0.26 0.38 0.44 Increase
MS12 0.31 0.26 0.33 0.36 Increase
MS20 0.19 0 0.14 0.42 Increase
a 9 MS Mean ± se 0.56 ± 0.08 0.50 ± 0.11 0.56 ± 0.08 0.60 ± 0.06 -
b 5 MS Mean ± se 0.48 ± 0.12 0.42 ± 0.16 0.47 ± 0.12 0.56 ± 0.09 -
HE = expected heterozygosity.
a All 9 markers used in analysis.
b Analysis restricted to 5 markers deﬁned as balanced by Sutton [35]: MS1, MS5, MS10, MS12, MS20.
doi:10.1371/journal.pone.0151514.t002
Table 3. Population diversity and LD in the ROK between 1994 and 2013.
Study No. samples No. markers Collection years HE ± SE Multilocus LD, ISA (P-value)
Iwagami et al. [10] 81 14 a 1994–1998 0.32 ± 0.04 0.584 (P < 0.001)
Honma et al. [8] 29 13 b 1997–2000 0.38 ± 0.06 0.557 (P < 0.001)
Iwagami et al. [10] 53 14 a 1999–2003 0.41 ± 0.03 0.315 (P < 0.001)
Iwagami et al. [10] 29 14 a 2004–2008 0.50 ± 0.05 0.140 (P < 0.001)
Honma et al. [8] 29 13 b 2007 0.55 ± 0.06 0.181 (P < 0.001)
This study 96 9 c 2010–12 0.56 ± 0.08 0.098 (P < 0.01)
a MS1, MS2, MS3, MS4, MS5, MS6, MS7, MS8, MS9, MS10, MS12, MS15, MS16, MS20.
b pv1.501, pv3.27, pv3.502, pv14.297, MS3, MS5, MS6, MS8, MS9, MS10, MS16, MS15, MS16, MS20.
c pv3.27, msp1F3, MS1, MS5, MS8, MS10, MS12, MS16, MS20.
doi:10.1371/journal.pone.0151514.t003
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4 markers also happened to be amongst the set of 5 markers defined as having balanced diver-
sity [35]. Although the overall diversity was lower using the 5 balanced markers (HE = 0.48)
versus the 9 markers (HE = 0.56), the trend of increasing diversity from 2010 (HE = 0.42) to
2011 (HE = 0.47) and 2012 (HE = 0.56) was maintained (P<0.05) (Table 2).
Relative to other geographic regions investigated in our other APMEN studies, the MS20
locus was notable not just in its low diversity in the ROK but also its moderately distinct allele
size range in this population (S4 Table). Other than a single ROK infection displaying MS20
allele 175, all isolates carried relatively short alleles, namely alleles 142 or 149. Neither of these
short MS20 alleles were observed in any of the imported cases investigated in this study (alleles
194, 218 and 233 observed) or in our other studies conducted in Malaysia [11], Indonesia [25],
Ethiopia [13] or Bhutan (manuscript under review), despite moderate to high diversity at the
locus in all of these sites.
Parasite Relatedness
Of the 77 ROK samples with complete data across the 9 loci, 64 distinct MLGs were observed,
55 (86%) of which were observed once, 6 (9%) twice, 2 (3%) three times, and 1 (1.5%) four
times. Broken down by year, 21, 32 and 19 distinct MLGs were observed in 2010, 2011 and
2012 respectively. In each year, the majority of MLGs were only observed once; 18(86%) in
2010, 30 (94%) in 2011 and 19 (100%) in 2012. Seven of the nine (78%) multiply observed
MLGs were present in more than one year, with two persisting from 2010 to 2012. The neigh-
bour-joining tree in Fig 2 (panel A), illustrates that the 9-locus MLGs did not demonstrate any
notable clustering by year of collection. This pattern was maintained when neighbour-joining
analysis was restricted to the 5 balanced markers (Fig 2, panel B).
Population Differentiation and Structure
Using both the 9 marker and 5 marker datasets, there was no evidence of genetic differentiation
between any of the study years (FST range: -0.006–0.030; F’ST range: -0.010–0.067) (S3 Table).
Using the delta Kmethod to assess the output of STRUCTURE analysis in the 9 marker data-
set, the most likely number of sub-populations was identified as 3 or 5, although the delta K for
both estimates was low (delta K = 12 and 13 respectively) (S1 Fig). At K = 2, there was no differ-
ence in population structure between the three study years (S2 Fig). At K = 5, there was an increase
in the number of isolates with high ancestry (70%; white colour code in S2 Fig) from 2010
(n = 0) to 2011 and 12 (n = 10).The isolates in the K5 cluster also exhibited moderate divergence
relative to the majority of the ROK isolates, and several clustered with the three imported cases.
When STRUCTURE analysis was restricted to the 5 balanced markers, the delta Kmethod
identified K = 2 as the most likely number of sub-populations (delta K = 44) (S2 Fig). The 5
marker neighbour-joining tree provided in the supplementary material (S3 Fig), demonstrates
that the K2 sub-population comprised of more diverged isolates relative to the K1 sub-popula-
tion. However, there were no notable differences in the proportions of K1 and K2 between the
study years (S4 Fig).
Linkage disequilibrium
The overall level of LD was moderate but significant (IA
S = 0.098, P<0.05) (Table 4). When
stratified by year, there was a trend of decreasing LD from 2010 (IA
S = 0.151, P<0.05) to 2011
(IA
S = 0.094, P<0.05) and 2012 (IA
S = 0.049, P<0.05). When the analysis was restricted to the 5
balanced markers, the decrease in LD was observed from 2010 (IA
S = 0.118, P<0.05) to 2011
(IA
S = 0.070, P<0.05) but not 2012 (IA
S = 0.078, P<0.05), possibly reflecting the combination
of limited number of markers and sample size in the latter year (Table 4). After adjusting for
P. vivax Diversity in the ROK
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multiply observed MLGs, LD remained significant in all years when the 9 marker set was
applied. However, the temporal trend was no longer apparent using the 5 marker set, likely
reflecting a limited ability to resolve distinct infections. Comparison of the current data with
that from ROK studies of earlier years [8, 10] suggested an overall trend of declining LD from
1994 to 2013 (Table 3).
Discussion
Using isolates sourced between 2010 and 2012, our study presents the most recent STR-based
analysis of P. vivax diversity and transmission in the ROK to date. Our results complement
Fig 2. Unrooted neighbour-joining trees illustrating the genetic relatedness between P. vivax isolates
in different years.Results derived from the 9 marker dataset in the top panel (A), and the 5 marker dataset in
the bottom panel (B). N = 79 and 83 in panels A and B respectively.
doi:10.1371/journal.pone.0151514.g002
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those from previous studies and provide further evidence of increasing population diversity
and declining LD over the years since re-emergence. Relative to other vivax-endemic regions,
the diversity of P. vivax in the ROK between 2010 and 2013 has remained moderately low, LD
is moderate but significant and polyclonal infections are rare. Sub-structure was apparent in
the population, with strongest evidence of 2 co-circulating sub-populations. We discuss the
possible epidemiological processes driving these patterns of diversity and structure.
Since re-emergence in 1993, vivax malaria in the ROK has largely been confined to regions
adjacent to the DMZ, raising suggestion that the DPRK is a major reservoir of infection. Anophe-
les sinensis has been shown to travel up to 12 km in a single night, theoretically permitting tra-
versal across the approximately 4 km wide DMZ [47]. Furthermore, ROK travellers are allowed
to visit certain regions of the DPRK including Kaesong and Kumgang san. Incidence data also
provides links between the vivax situation in the ROK and DPRK. In the early 2000s, the DPRK
experienced its highest reported incidence of malaria, peaking at approximately 150,000 cases:
this coincided with a peak incidence in the ROK, with over 4,000 cases reported [48]. Shortly
after this period, the ROK began donating funds via theWorld Health Organization to the
DPRK to aid malaria control efforts, and the incidence of vivax malaria declined in both the
DPRK and the ROK [48]. Besides the potential influence of direct introductions from the DPRK,
local transmission events have likely also had moderate impact on the genetic structure of the
ROK vivax population in recent years as the proportion of civilian cases has increased.
The most recent peak incidence in the ROK was observed in 2010 (1,722 cases) followed by
a decline to 838 in 2011 and 555 in 2012 [48]. Our analyses on samples collected during these
years demonstrated an overall expected heterozygosity of 0.56. In the majority of vivax-
endemic countries investigated to date, HE frequently exceeds 0.8 [13, 14, 16, 19, 21–23, 25, 26,
29]. In this respect, the diversity observed in the ROK can be considered moderately low, with
levels most comparable to low endemic settings in Sabah, Malaysia (HE 0.58–0.67) [11] and
Loreto, Peru (HE 0.44–0.69) [30], inferring low transmission within the ROK.
At 3%, the prevalence of polyclonal infections between 2010 and 12 was also low. Indeed,
even after reducing the threshold for calling minor alleles to 10% intensity of the major clone,
Table 4. Linkage disequilibrium.
All infections 1 Unique MLGs 2
Year Marker Set N IAS N IAS
2010 3 9 MS 24 0.151* 21 (88%) 0.106*
4 5 MS 25 0.118* 13 (52%) 0.0111*
2011 3 9 MS 34 0.094* 32 (94%) 0.089*
4 5 MS 36 0.070* 20 (56%) -0.035 NS
2012 3 9 MS 19 0.049* 19 (100%) 0.049*
4 5 MS 19 0.078* 15 (79%) 0.026*
2010–13 3 9 MS 77 0.098* 64 (83%) 0.070*
4 5 MS 80 0.082* 33 (38%) -0.013 NS
1Only samples with no missing data at all 8 loci are included in the analyses. Note, all samples exhibited low complexity, hence there was no need to
repeat the analysis with samples restricted to a maximum of one multi-allelic locus.
2 Unique set of multi-locus genotypes.
3 All 9 markers used in analysis.
4 Analysis restricted to 5 markers deﬁned as balanced by Sutton [35]: MS1, MS5, MS10, MS12, MS20.
*0.01 < P < 0.05.
NS Not signiﬁcant (P > 0.05).
doi:10.1371/journal.pone.0151514.t004
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only 6% of infections were polyclonal. Caution is advised in inter-study comparisons of poly-
clonality as the number and nature of markers as well as methods used for calling minor alleles
is recognised to play a major role in the detection of polyclonal infections [49]. However, com-
parison is possible with APMEN studies using similar methodologies which reported polyclon-
ality ranging from 4–12% in Central China [23], 26% in Malaysia [11], 30% in the Solomon
Islands [14], 8–67% in Ethiopia [13], and 23–70% in Indonesia [25]. The low prevalence of
polyclonal infections in the ROK demonstrated greatest comparability to Central China. These
observations are consistent with a major contribution of the nature of relapse in shaping
within-host infection diversity in P. vivax, the latency from ROK and Central China being less
frequent with longer latency than the other studies so far reported. Low incidence and accord-
ingly low rates of superinfection may also facilitate low rates of polyclonal infection.
Across 2010–12, significant LD was observed in the ROK, with a moderate index of associa-
tion (IA
S = 0.1, P<0.05) relative to other geographic regions. IA
S<0.01 with no evidence of LD
has been observed in parts of Indonesia [25], Papua New Guinea [22] and Ethiopia [13], and at
the other extreme, significant LD with IA
S>0.25 has been observed in Sabah [11], Central
China [23], and parts of Peru [30]. The mechanisms shaping LD in P. vivax remain poorly
understood. In P. falciparum populations, genetic diversity tends to be reduced and LD
enhanced in low transmission settings [50, 51]. This pattern is postulated to reflect the pre-
dominance of monoclonal infections in low transmission settings and consequently greater fre-
quency of inbreeding. However, several P. falciparum studies and a large number of P. vivax
studies have demonstrated significant LD in the presence of high population diversity and fre-
quent polyclonal infections, leading to suggestions that other processes might also shape LD in
Plasmodium (reviewed in [52]).
The paucity of polyclonal infections in the ROK supports largely clonal propagation dynam-
ics, although the modest LD infers only a moderate degree of inbreeding. We considered that
this unusual dynamics might reflect underestimation of the extent of LD in the ROK owing to
features of the markers applied. Indeed, during mitotic replication, strand-slippage events may
occur moderately frequently in microsatellites rendering them less stable than SNPs. However,
the aforementioned studies in Sabah and Central China were able to detect strong LD using the
same marker sets [11, 23]. Further, although the microsatellite panel was not identical to the
panel applied here (5 shared markers), Iwagami and colleagues demonstrated the persistence
of alleles for up to 10 years in the ROK, inferring moderate stability [9]. Additional studies
using neutral SNP-based markers are nonetheless needed to confirm the genetic structure of P.
vivax in the ROK.
We also considered that we may have underestimated the frequency of polyclonal infections
in the ROK. On reducing the threshold for calling minor alleles from 33% to 10%, the preva-
lence of polyclonal infections remained low at 6%. Whilst we might identify more clones at
lower relative thresholds, the chances of minor clones being sampled in a mosquito blood meal
and consequent recombination would decline. Genotyping at additional markers would likely
also reveal more polyclonal infections. By definition, however, the clones within the infection
would be highly related. Further, as demonstrated in Indonesia, with 70% polyclonal infections
in Sumba [25], the APMENmarker set has high potential to detect polyclonal infections.
Another explanation for the modest LD is that parasites introduced from an external reser-
voir(s) have enhanced the number of apparent recombination events in the ROK. Indeed, sev-
eral previous genetic studies in the ROK have reached the conclusion that the extant vivax
population is heavily shaped by continuous introductions from the DPRK [9, 10, 53]. It should
be noted that this scenario does not exclude that local transmission events may also occur in
the ROK and thus also contribute to the population structure. Importantly, this explanation
allows for local propagation to take place largely by inbreeding, concordant with the low
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incidence, low prevalence of polyclonal infections, and limited period (July-August) of oppor-
tunity for recombination in the A. sinensis vector. This scenario also helps to explain the longi-
tudinal trends in the genetic diversity and structure of P. vivax in the ROK described further
below.
Despite the fluctuations in P. vivax incidence in the ROK, the data from this and other stud-
ies demonstrates a consistent rise in population diversity associated with a decline in LD over
the years [8, 10]. Although the increase in expected heterozygosity between 2010 and 2012 in
our study did not reach significance, the trend of increasing diversity in recent years is consis-
tent with observations from independent studies using both neutral [8, 10] and surface protein
markers [53–56]. The increasing diversity and declining LD might in part reflect an increase in
local outbreeding rates. A recent study using sequence data generated at the P. vivaxmerozoite
surface protein-1 gene (PvMSP1) demonstrated a gradual increase in the frequency of PvMSP1
recombinant types between 1996 and 2013, inferring increased outbreeding [57]. Indeed, the
increased proportion of cases in the civilian population might have facilitated the dissemina-
tion of infections and potential for local outbreeding. However, as mentioned previously, the
paucity of polyclonal infections restrains the extent of outbreeding in the ROK. Further, despite
the large number of distinct MLGs (n = 64), the majority of MLGs that were observed more
than once (7/9, 78%) persisted across two to three years without being broken down by recom-
bination. An increase in the rates of local outbreeding alone is therefore unlikely to have led to
the increased divergence in the parasite population.
An additional factor that may have facilitated the increase in population diversity and
decline in LD is introductions of cases from an external reservoir(s). Indeed, the declining inci-
dence of vivax cases in the ROK may have been associated with an increase in the relative pro-
portion of externally sourced cases. As per earlier discussions, the introduction of cases from
an external reservoir would permit diversity to increase in the ROK without the need for exten-
sive outbreeding to take place locally. This scenario would therefore not conflict with the low
rate of polyclonal infections observed or low incidence. Indeed, a recent study in the pre-elimi-
nation setting of Sri Lanka identified a similar paradox of increasing P. vivax diversity as local
transmission levels declined: the authors concluded that this reflected increased diversity from
imported infections [15]. The number of overseas imported cases reported in the ROK remains
low (below 50 per year) despite a modest increase in the past few years [48]. However, these fig-
ures do not account for the burden of infections from the DPRK, which is less easily measured,
and more likely to be a reservoir to the ROK. However, this remains speculative: genetic data
on the DPRK vivax population is needed to gain better insight into the extent of genetic
exchange with the ROK population.
Whilst STR markers are not ideal for investigating parasite geographic origin (mitochon-
drial data being preferable in most endemic regions [58]), we observed that, with the exception
of a single isolate, all of the ROK infections carried a short MS20 allelic form (142 or 149 bp).
Neither of the short MS20 alleles were observed in any of the imported cases investigated in
this study or in our other studies conducted in Malaysia [11], Indonesia [25], Ethiopia [13] or
Bhutan (manuscript under review) despite moderate to high diversity at the locus in all of
these sites (HE range: 0.69–0.92), demonstrating potential population-specificity of these
alleles. It remains to be confirmed whether the short MS20 allelic form is found in the DPRK
and whether it is exclusive to the Korean Peninsula. Nonetheless, the current evidence suggests
that the MS20 locus is likely to be diverse in most other endemic regions and thus these regions
are not likely to be major reservoirs of vivax malaria to the ROK. Rather, a restricted geo-
graphic region, most likely the DPRK given the epidemiological evidence, constitutes the main
external reservoir of P. vivax infection to the ROK.
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The ROK studies referenced in the temporal trends used different marker sets, with Honma
et al. and Iwagami et al. applying 5/9 and 7/9, respectively, of the markers used in our current
analysis. Nonetheless, the trend of increasing diversity and declining LD is replicated within
the current study as well as that of Honma et al. and Iwagami et al., suggesting that the inter-
study observations are unlikely to be an artefact of the different marker sets used.
Analysis of the local population structure using STRUCTURE software highlighted a greater
capacity to detect subtle patterns of population structure when loci with excess diversity are
excluded. Whilst delta K analysis of the 9 marker STRUCTURE output demonstrated weak evi-
dence of 3 or 5 sub-populations in the ROK, when analysis was restricted to the 5 balanced
markers, there was clear evidence for 2 sub-populations. Closer inspection of the isolates within
each of the two sub-populations revealed that the isolates in the K2 cluster were generally more
divergent than those in the K1 sub-population A previous study undertaken on P. vivax isolates
collected in the ROK between 1994 and 2008 identified temporal changes in the local popula-
tion structure reflecting increased diversity in the population in 2002 and 2003 [10]. We did
not find any evidence of temporal trends in the distribution of the K1 and K2 isolates in our
study, likely reflecting the limited time scale. Using mitochondrial sequence data, Iwagami and
colleagues have previously postulated that two sub-populations observed in ROK isolates
reflected long versus short latency infections on account of their clustering patterns in relation
to other geographic isolates [59]. Owing to constraints in the availability of phenotypic data on
infection latency, we were unable to assess this hypothesis in our study. Further studies with
precisely defined latency and clinical phenotypes would lend additional insights, but it is likely
that other epidemiological factors also underlie the observed structure.
Conclusions
Whilst the underlying factors responsible for the trends observed in the diversity and structure
of P. vivax in the ROK remain inconclusive, the available evidence suggests that introduced
infections sourced from a single major reservoir of infection with moderate diversity has an
important role in sustaining P. vivax infection in the ROK. These findings have critical implica-
tions for malaria control in this region and its elimination.
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